Accolade, Inc. - common stock (NQ:ACCD)

7.020 UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 7, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Accolade, Inc. - common stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday ↗

March 01, 2025

Ark Invest made notable trades on Feb. 28, 2025. They purchased shares in ACHR, RXRX, TEM, and IRDM, while selling shares in TWST, ADYEY, ACCD, and EXAS.

Via Benzinga

Topics Artificial Intelligence

ACCD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Accolade, Inc. Is Fair to Shareholders

February 25, 2025

From Halper Sadeh LLC

Via Business Wire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, FNA, LGTY, ACCD on Behalf of Shareholders

February 19, 2025

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Accolade, Inc. (Nasdaq - ACCD), Paragon 28, Inc. (NYSE - FNA), Logility Supply Chain Solutions, Inc. (Nasdaq - LGTY), Enfusion, Inc. (NYSE - ENFN)

February 19, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday ↗

February 08, 2025

Ark Invest made significant trades on Friday, including buying Amazon and Roblox stock and selling Palantir stock. Other key trades were also made.

Via Benzinga

Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox ↗

January 31, 2025

Cathie Wood-led Ark Invest made significant trades involving CRSP, TXG, RBLX, ACHR, NU, ADYEY, ACCD, and AVAV.

Via Benzinga

Cathie Wood's Wednesday Moves: Ark Invest Dumps Robinhood Stock ↗

January 22, 2025

On Wednesday January 22, 2025, Cathie Wood-led Ark Invest sold $927,107 worth of Robinhood shares.

Via Benzinga

Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies ↗

January 22, 2025

Cathie Wood-led Ark Invest made significant trades involving ACCD, DE, NTLA, PATH, CCJ, OKLO, ILMN, ESLT, and ABSI.

Via Benzinga

Topics Government

Accolade Q3 Earnings Assessment ↗

January 10, 2025

Via Benzinga

Earnings Scheduled For January 9, 2025 ↗

January 09, 2025

Via Benzinga

Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia ↗

January 18, 2025

Ark Invest made significant trades involving Tempus AI, CRISPR Therapeutics, UiPath, Roblox, Reddit, Accolade, and Ibotta. ARKG and ARKK funds bought shares, while ARKW and ARKF funds sold shares.

Via Benzinga

Topics Artificial Intelligence

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), Paycor HCM, Inc. (Nasdaq - PYCR), Accolade, Inc. (Nasdaq - ACCD)

January 13, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates SSTK, ACCD, ESSA, AKYA on Behalf of Shareholders

January 11, 2025

From Halper Sadeh LLC

Via GlobeNewswire

What's Going On With Accolade Stock Wednesday? ↗

January 08, 2025

Accolade shares are trading higher on Wednesday after it announced that Transcarent will acquire the company.

Via Benzinga

Breaking Down Accolade: 8 Analysts Share Their Views ↗

December 17, 2024

Via Benzinga

ACCOLADE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Accolade, Inc. - ACCD

January 08, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 08, 2025

Via Benzinga

Why Is Accolade Stock Trading Over 100% On Tuesday? ↗

January 08, 2025

Transcarent to acquire Accolade Inc. for $7.03 per share, combining AI-driven care solutions with personalized healthcare expertise. Deal closes Q2 2025.

Via Benzinga

Shareholder Alert: Ademi LLP Investigates Whether Accolade, Inc. Is Obtaining a Fair Price for Its Public Shareholders

January 08, 2025

From Ademi LLP

Via Business Wire

Forecasting The Future: 6 Analyst Projections For Accolade ↗

October 09, 2024

Via Benzinga

Uncovering Potential: Accolade's Earnings Preview ↗

October 07, 2024

Via Benzinga

Top Wall Street Forecasters Revamp Accolade Price Expectations Ahead Of Q2 Earnings ↗

October 04, 2024

Via Benzinga

ACCD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Accolade, Inc. Is Fair to Shareholders

January 08, 2025

From Halper Sadeh LLC

Via Business Wire

Transcarent To Acquire Accolade

January 08, 2025

From Transcarent

Via Business Wire

Transcarent To Acquire Accolade

January 08, 2025

From Accolade, Inc.

Via GlobeNewswire

Accolade's Q2 Boost: Revenue Rises, Losses Shrink, And Profitability Looms ↗

October 08, 2024

Accolade stock up after beating Q2 2025 revenue and EPS estimates, expecting full year Adjusted EBITDA profitability and positive cash flow.

Via Benzinga

Accolade Announces Results for Fiscal Second Quarter 2025

October 08, 2024

From Accolade, Inc.

Via GlobeNewswire

Dow Dips Around 400 Points As Treasury Yields Top 4%: Investor Optimism Declines, But Fear Index Remains In 'Greed' Zone ↗

October 08, 2024

Via Benzinga

Topics Stocks

PepsiCo, MEDIROM Healthcare Technologies And 3 Stocks To Watch Heading Into Tuesday ↗

October 08, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 04, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.